US 10683277
Triazole derivatives as P2Y14 receptor antagonists
granted A61PA61P3/00
Quick answer
US patent 10683277 (Triazole derivatives as P2Y14 receptor antagonists) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P3/00